Purple Biotech Ltd
PPBT
$3.95
$0.102.55%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -5,642.68% | 54.89% | 91.51% | 86.83% | |
| Total Depreciation and Amortization | 32.50% | -4.08% | -16.67% | -2.00% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 3,309.22% | 83.89% | 49.13% | -410.69% | |
| Change in Net Operating Assets | 287.85% | 60.66% | -195.08% | -184.36% | |
| Cash from Operations | 47.02% | 61.17% | 59.57% | 9.87% | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -350.00% | 25.29% | -48.65% | -92.84% | |
| Cash from Investing | -373.68% | 22.99% | -48.65% | -92.84% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -27.08% | 15.22% | -14.29% | -4.76% | |
| Issuance of Common Stock | -94.09% | -21.45% | 109,075.00% | 273.45% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 126.32% | 55.29% | -108.87% | -453.13% | |
| Cash from Financing | -92.46% | -15.47% | -7.23% | 273.08% | |
| Foreign Exchange rate Adjustments | -- | 800.00% | -100.00% | 115.00% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -144.57% | 70.07% | 419.19% | 48.24% | |